WHO ICTRP trial
A multicenter, open-label, non-inferiority, randomized controlled trial…
NL-OMON25145 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON25145 |
|---|---|
| Public title | A multicenter, open-label, non-inferiority, randomized controlled trial comparing mechanochemical endovenous ablation using Flebogrif with endovenous laser ablation in the treatment of primary great saphenous vein incompetence |
| Scientific title | A multicenter, open-label, non-inferiority, randomized controlled trial comparing mechanochemical endovenous ablation using Flebogrif with endovenous laser ablation in the treatment of primary great saphenous vein incompetence |
| Primary sponsor | Noordwest Ziekenhuisgroep |
| Secondary sponsors | Angiocare |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | 4 |
| Conditions | Great spahenous vein incompetence GSV incompetence;10057165;GSV incompetence |
| Interventions | Flebogrif vs EVLA ;Medical device or in-vitro diagnositcs |
| Registration date | Feb 9, 2021 |
| Target size | 320 |
| Secondary IDs | NL9527;NL74491.029.20 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: